Nikita Shah

Insider Reports History

Entity
Individual
Location
C/O Amneal Pharmaceuticals Llc, 400 Crossing Blvd, Bridgewater, NJ
Signature
/s/ Denis Butkovic, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Nikita Shah:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Amneal Pharmaceuticals, Inc. Executive Vice President Class A Common Stock 292K $2.26M $7.75 Aug 14, 2024 Direct
Amneal Pharmaceuticals, Inc. Executive Vice President Performance-Based Restricted Stock Units 287K $1.64M $5.71 Mar 4, 2024 Direct
Amneal Pharmaceuticals, Inc. Executive Vice President Restricted Stock Units 144K $819K $5.71 Mar 4, 2024 Direct

Insider Reports Filed by Nikita Shah

Symbol Company Period Transactions Value $ Form Type Date Filed Role
AMRX Amneal Pharmaceuticals, Inc. Aug 14, 2024 1 -$775K 4 Aug 16, 2024 Executive Vice President
AMRX Amneal Pharmaceuticals, Inc. Mar 1, 2024 11 -$308K 4 Mar 5, 2024 Executive Vice President
AMRX Amneal Pharmaceuticals, Inc. Feb 27, 2024 3 -$107K 4 Feb 29, 2024 Executive Vice President
AMRX Amneal Pharmaceuticals, Inc. Mar 3, 2023 5 -$34.7K 4 Mar 7, 2023 Executive Vice President
AMRX Amneal Pharmaceuticals, Inc. Mar 1, 2023 6 -$46.1K 4 Mar 3, 2023 Executive Vice President
AMRX Amneal Pharmaceuticals, Inc. Feb 27, 2023 3 -$42.7K 4 Mar 1, 2023 Executive Vice President
AMRX Amneal Pharmaceuticals, Inc. May 7, 2022 3 -$7.58K 4 May 10, 2022 Executive Vice President
AMRX Amneal Pharmaceuticals, Inc. Mar 1, 2022 8 -$55.7K 4 Mar 3, 2022 Executive Vice President
AMRX Amneal Pharmaceuticals, Inc. Feb 27, 2022 3 -$53.7K 4 Mar 1, 2022 Executive Vice President
AMRX Amneal Pharmaceuticals, Inc. Dec 15, 2021 1 -$7.9K 4 Dec 17, 2021 Executive Vice President
AMRX Amneal Pharmaceuticals, Inc. May 7, 2021 3 -$7.1K 4 May 11, 2021 Executive Vice President